Multivariate survival analysis revealed that high tumor grade and low expression of SNCG were predictors of poorer survival outcomes in MBC patients, while low expression of CCAT2 was the only predictor of poor prognosis in NMBC patients. The gene discussed is CCAT2; the disease is neoplasm.